@tom_the_bomb__ Tom, I think BP knows about us already mate but I like what you're at π. I hope you are enjoying your holidays relaxing and knowing what is soon coming our way. We are completely de-risked.
@Chrisjo35828676 It's such a pity the market always gets jittery before our big announcements which is no doubt why we are seeing the SP fall back when the mood from yesterday AGM was very positive
@AIMForTheBULL@JStonker I don't want to hear about her getting feedback.. it's not a bloody survey we're carrying out! Why does she need "a determined spirit"(presumably to succeed) but this should be a given on her salary. I recently topped up with almost as many shares as she did. Less cryptic BS pls
@tom_the_bomb__@SeanDentBsc Thanks for the reply Tom. It's extremely helpful for investors like myself who don't have your extensive of how this industry works.. assuring to know that bio medical sciences work differently to other business. Fingers crossed we get good news on TNBC.
@tom_the_bomb__@SeanDentBsc Tom, I'd love to think it would (make a dent in the vastly bigger TNBC market) but I just don't think we should get our hopes up - good TNBC read outs would have allowed us to a deal (rather than a raise) when AVA 6000 results land in only a few weeks time.
@tom_the_bomb__@NstaM0 Tom, I'm a big fan mate but not your best response, imo. All those scenarios have 't happened so it's a completely moot point you are making. Keep ur positivity coming and if management are misleading us ,there will be hell to pay! End of June is market deadline for deal imo.
@Mike182035 Mike, I totally disagree with you. Management have been telling us all along they won't take 6000 into P2 without a partner. No partner announcement now then signals a lack of interest/value from would be partners and inevitably our SP will be decimated in the short term.
@JStonker Thanks Stonks. Forgive my ignorance but is this not the same information which was disclosed in this morning's RNS which wasn't well very well received by the market (6% SP fall) or is there a little nugget in there which I am missing and might just reverse the dip tomorrow?
@TVR5AVCT TVR5, I read it stronger than that. It is now almost a given that we are about to partner AV6000 into Phase2. Probably about time of TNBC data release end of June? Confident investors need to be less vague with their messaging.
@tom_the_bomb__@Cumulus51896691 Could they expand to other cancers? From your reply Tom assume they are only pancreatic but if expanded they will be a competitor?sorry but I'm not at all delighted for them, a heartless reply as it's good news for patients.
@tom_the_bomb__ Or is there a lot of editing required with CC supposedly dropping more than a hint or two eg smiling when asked about how (positively) A6103 trial was going? That might be construed as straying into tricky territory with the regulator and release of market sensitive info?
@RAH00084@tom_the_bomb__@avacta Added another Β£25,000 this morning at 84p. The industry has finally awoken to the massive undervaluation of what Avacta has here. Daiichi's Β£600m loss on their disappointing sales of their much lauded ADC Enhertu which Avacta claim will be blown out of the water is why we are π